Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Acadia Pharmaceuticals (Nasdaq: ACAD) announced its participation in two upcoming virtual investor conferences. The Jefferies 2021 Virtual Healthcare Conference will feature a fireside chat on June 2, 2021, at 1:30 p.m. ET, followed by the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, at 2:10 p.m. ET. Live webcasts of both presentations will be available on Acadia's website, with archived recordings accessible for one month post-event. Acadia is focused on neurological solutions, including therapies for Parkinson's disease psychosis and dementia-related psychosis.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following investor conferences:

Jefferies 2021 Virtual Healthcare Conference
Fireside Chat Presentation: Wednesday, June 2, 2021 at 1:30 p.m. Eastern Time

Goldman Sachs 42^nd Annual Global Healthcare Conference
Fireside Chat Presentation: Tuesday, June 8, 2021 at 2:10 p.m. Eastern Time

These conferences will be held virtually. Live webcasts of the presentations will be accessible on the company’s website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation.

About Acadia Pharmaceuticals

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson’s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research we are exploring novel approaches to pain management, and cognition and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210526005191/en/

FAQ

When is Acadia Pharmaceuticals presenting at the Jefferies Conference?

Acadia Pharmaceuticals will present at the Jefferies 2021 Virtual Healthcare Conference on June 2, 2021, at 1:30 p.m. ET.

What date is Acadia Pharmaceuticals' presentation at the Goldman Sachs Conference?

The Goldman Sachs 42nd Annual Global Healthcare Conference presentation by Acadia Pharmaceuticals is scheduled for June 8, 2021, at 2:10 p.m. ET.

Where can I watch Acadia Pharmaceuticals' conference presentations?

The live webcasts of Acadia Pharmaceuticals' presentations will be available on their website under the investors section.

What is Acadia Pharmaceuticals focused on?

Acadia Pharmaceuticals specializes in neuroscience, developing therapies for conditions like Parkinson's disease psychosis and dementia-related psychosis.